Chemoablation of tissue using biodegradable, solid salt dosage forms
View Patent ↗Novel methods for the chemical ablation of tissue (e.g. prostatic tissue) are described. These methods include the steps of: (a) providing one or more solid salt dosage form comprising 50-100% w/w salt; and (b) inserting one or more of such solid salt dosage forms into the tissue. The solid salt dosage form is optionally inserted into the tissue under real-time ultrasonic observation. An advantage of the present invention is its ability to eliminate toxic byproducts. For example, where NaCl-based solid salt dosage forms are used to effect localized chemical ablation, the concentration is ultimately reduced to the level of normal saline (i.e., about 0.9%) upon absorption by the body of the subject being treated.
1. A method for the chemical ablation of prostatic tissue in need of chemical ablation, said method comprising: (a) providing a solid salt dosage form comprising 50–100% w/w alkali metal halide salt selected from the group consisting of potassium chloride, sodium chloride, and a combination thereof, said solid salt dosage form ranging in volume from 0.5 mm 3 to 25 mm 3 ; and (b) inserting said solid salt dosage form into said tissue in a number sufficient to achieve chemical ablation.
2. The method of claim 1 , wherein said salt is sodium chloride.
3. The method of claim 1 , wherein said solid salt dosage form further comprises a polymer coating.
4. The method of claim 1 , wherein said solid salt dosage form is injected into said tissue under real-time ultrasonic observation.
5. The method of claim 1 , wherein said solid salt dosage form is inserted into said tissue by pushing said dosage form through a hollow sheath.
6. The method of claim 1 , wherein said tissue is prostatic tissue displaying benign prostatic hypertrophy.
7. The method of claim 1 , wherein said tissue is prostatic tissue displaying prostate cancer.
8. The method of claim 6 , wherein said salt is sodium chloride.
9. The method of claim 6 , wherein said solid salt dosage form is injected into said prostatic tissue under real-time ultrasonic observation.
10. The method of claim 6 , wherein said solid salt dosage form is inserted into said prostatic tissue by pushing said dosage form through a hollow sheath.
11. The method of claim 6 , wherein a plurality of said dosage forms are inserted into said prostate tissue.
12. The method of claim 6 , wherein said solid salt dosage form is transrectally inserted into said prostate tissue.
13. The method of claim 6 , wherein said solid salt dosage form is transperineally inserted into said prostate tissue.
14. The method of claim 6 , wherein said solid salt dosage form is transuretherally inserted into said prostate tissue.
15. The method of claim 6 , wherein said solid salt dosage form is transrectally inserted into said prostate tissue under real-time ultrasonic observation.
16. The method of claim 15 , wherein said salt dosage form includes sodium chloride.
17. The method of claim 1 , wherein said solid salt dosage form is inserted into said tissue by an apparatus comprising: (a) a shaft comprising a longitudinal lumen; (b) a magazine adapted to hold a plurality of said dosage forms, said magazine comprising an outlet; and (c) a pushing member for pushing said dosage forms from a position proximate said magazine outlet, through said lumen of said flexible shaft and into said tissue.
18. The method of claim 17 , wherein said shaft is flexible and adapted for penetration of said tissue.
19. The method of claim 17 , wherein said shaft is rigid and adapted for penetration of said tissue.
20. The method of claim 17 , wherein said pushing member is adapted for penetration into said tissue.
21. The method of claim 17 , wherein said apparatus further comprises an ultrasound probe.